4th Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$51,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Monitoring the impact of sequestration on FDA funding H.R. 6190: Asthma Inhalers Relief Act of 2012 S. 1206 Medicare Drug Savings Act of 2011 Monitored draft pedigree legislation (Bennet-Burr)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President 2002-2005 |
Labor Issues/Antitrust/Workplace LBR
S. 27 Preserve Access to Generic Drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President (2002-2005) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.